Romidepsin D7
| Product Name | Romidepsin D7 |
|---|---|
| Alternate Names | Romidepsin Stable Isotopes, Stable Isotopes of Romidepsin |
| CAT No. | CS-O-11359 |
| CAS No. | 128517-07-7(Unlabeled) |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 547.74 g/mol |
| Mol. For. | C₂₄H₂₉D₇N₄O₆S₂ |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Romidepsin |
| Purity | 95% |
| Therapeutic | Anti-Cancer / Oncology |
| Smileys | O=C(N/C(C(N[C@@](C(O1)=O)([H])C([2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])=O)=C\C)[C@](CSSCC/C=C/[C@]1([H])CC2=O)([H])NC([C@H](N2)C(C)C)=O |
| Canonical Smiles | CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C |
| InchIKey | OHRURASPPZQGQM-GCCNXGTGSA-N |
| Inchl | InChI=1S/C24H36N4O6S2/c1-6-16-21(30)28-20(14(4)5)24(33)34-15-9-7-8-10-35-36-12-17(22(31)25-16)26-23(32)19(13(2)3)27-18(29)11-15/h6-7,9,13-15,17,19-20H,8,10-12H2,1-5H3,(H,25,31)(H,26,32)(H,27,29)(H,28,30)/b9-7+,16-6-/t15-,17-,19-,20+/m1/s1 |
| IUPAC | (1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Romidepsin D7 is a deuterated version of Romidepsin, which is a drug used for the treatment of cutaneous and peripheral T-cell lymphoma. Romidepsin D7 is a class of histone deacetylase inhibitors (HDAC inhibitors), which means that it works by blocking the activity of enzymes that regulate gene expression.
HDAC inhibitors such as Romidepsin D7 have been shown to modulate the immune system and can be used as anti-cancer agents. Romidepsin D7 has been used in clinical trials to evaluate its efficacy and safety in the treatment of various cancers.
The chemical formula of Romidepsin D7 is C24H32D7N4O6S2, and it has a molecular weight of 564.76 g/mol. It is a white to off-white powder that is soluble in water and other polar solvents. The deuterated version of Romidepsin is used in research and clinical settings to track the drug's metabolism and distribution in the body.
Like other drugs, Romidepsin D7 has potential side effects, such as nausea, vomiting, diarrhea, fatigue, and decreased appetite. It is important to consult a healthcare professional before using Romidepsin D7, and to report any adverse reactions or symptoms while taking the drug.
Overall, Romidepsin D7 is a promising drug in the treatment of cancer, and ongoing research and clinical trials will help to further elucidate its efficacy and safety.
Get an Instant Quote
Related Compounds
Romidepsin-d8 |